Daiwa Securities Group Inc. Halozyme Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

$23.7 Billion
Q1 2025

A detailed history of Daiwa Securities Group Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 395 shares of HALO stock, worth $22,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

395

Previous 420 5.95%

Holding current value

$22,147

Previous $20,000 25.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$47.74 - $65.16 $1,193 - $1,629	-25 Reduced 5.95%	395 $25,000
Q4 2024 Feb 07, 2025	SELL	$42.57 - $61.09 $2,085 - $2,993	-49 Reduced 10.45%	420 $20,000
Q1 2024 May 02, 2024	SELL	$33.68 - $41.95 $2,391 - $2,978	-71 Reduced 13.15%	469 $19,000
Q4 2023 Jan 31, 2024	BUY	$33.32 - $42.1 $2,199 - $2,778	66 Added 13.92%	540 $20,000
Q2 2023 Jul 31, 2023	SELL	$30.28 - $38.74 $2,119 - $2,711	-70 Reduced 12.87%	474 $17,000
Q4 2022 Feb 06, 2023	BUY	$40.06 - $59.44 $1,201 - $1,783	30 Added 5.84%	544 $31,000
Q2 2022 Aug 09, 2022	BUY	$37.35 - $48.3 $3,847 - $4,974	103 Added 25.06%	514 $23,000
Q4 2021 Feb 03, 2022	SELL	$31.82 - $40.75 $2,418 - $3,097	-76 Reduced 15.61%	411 $17,000
Q3 2021 Nov 05, 2021	BUY	$38.47 - $46.42 $8,424 - $10,165	219 Added 81.72%	487 $20,000
Q1 2021 May 03, 2021	BUY	$39.51 - $51.45 $553 - $720	14 Added 5.51%	268 $11,000
Q4 2020 Feb 04, 2021	SELL	$25.81 - $43.62 $13,292 - $22,464	-515 Reduced 66.97%	254 $11,000
Q1 2020 May 14, 2020	SELL	$13.9 - $21.83 $806 - $1,266	-58 Reduced 7.01%	769 $14,000
Q4 2019 Jan 31, 2020	SELL	$14.93 - $19.53 $1,418 - $1,855	-95 Reduced 10.3%	827 $15,000
Q1 2019 Apr 26, 2019	BUY	$13.94 - $17.58 $1,881 - $2,373	135 Added 17.15%	922 $15,000
Q1 2018 May 02, 2018	BUY	$17.06 - $21.2 $13,426 - $16,684	787 New	787 $15,000

Others Institutions Holding HALO

# of Institutions

595

Shares Held

124M

Call Options Held

320K

Put Options Held

113K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.81B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Halozyme Therapeutics, Inc. Transaction History